Proof of principle for transfusion of in vitro-generated red blood cells

Blood

Volumn 118, Issue 19, 2011, Pages 5071-5079

  Giarratana, Marie Catherine ^a,b   Rouard, Hélène ^c,d   Dumont, Agnès ^e   Kiger, Laurent ^f   Safeukui, Innocent ^g   Le Pennec, Pierre Yves ^h   François, Sabine ^a,b,i   Trugnan, Germain ^j   Peyrard, Thierry ^h   Marie, Tiffany ^a,b,c   Jolly, Séverine ^a,b,c   Hebert, Nicolas ^a,b,c   Mazurier, Christelle ^a,b,c   Mario, Nathalie ^e   Harmand, Laurence ^a,b,c   Lapillonne, Hélène ^a,b,k   Devaux, Jean Yves ^e   Douay, Luc ^a,b,c,e  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b INSERM   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f BICÊTRE HOSPITAL   (France)

^g INSTITUT PASTEUR   (France)

^h INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

ⁱ INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^j SORBONNE UNIVERSITÉ   (France)

^k ARMAND TROUSSEAU HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD71 ANTIGEN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; PYRUVATE KINASE;

ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; GOOD MANUFACTURING PRACTICE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE COUNT;

EID: 81055124027     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-362038     Document Type: Article

References (48)

1. Migliaccio AR, Whitsett C, Migliaccio G. Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol. 2009;16(4):259-268.
2. Douay L, Lapillonne H, Turhan AG. Stem cells - a source of adult red blood cells for transfusion purposes: present and future. Crit Care Clin. 2009;25(2):383-398.
3. Douay L, Andreu G. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion? Transfus Med Rev. 2007;21(2):91-100. (Pubitemid 46486703)
4. Migliaccio G, Di Pietro R, di Giacomo V, et al. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis. 2002;28(2):169-180. (Pubitemid 34743751)
5. + cells. Transfusion. 2008;48(10):2235-2245.
6. Fujimi A, Matsunaga T, Kobune M, et al. Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages. Int J Hematol. 2008;87(4):339-350.
7. Neildez-Nguyen TM, Wajcman H, Marden MC, et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol. 2002;20(5):467-472. (Pubitemid 34495932)
8. Pourcher G, Mazurier C, Yong King Y, et al. Human fetal liver: an in vitro model of erythropoiesis. Stem Cells Int. 2011;2011:405429.
9. Ma F, Ebihara Y, Umeda K, et al. Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc Natl Acad Sci U S A. 2008;105(35):13087-13092.
10. Hiroyama T, Miharada K, Sudo K, Danjo I, Aoki N, Nakamura Y. Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One. 2008;3(2):e1544.
11. Lu SJ, Feng Q, Park JS, et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. 2008;112(12):4475-4484.
12. Lapillonne H, Kobari L, Mazurier C, et al. Red blood cells generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica. 2010;95:1651-1659.
13. Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc. 2007;2(12):3081-3089.
14. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-1920.
15. Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23(1):69-74. (Pubitemid 41724627)
16. Timmins NE, Nielsen LK. Blood cell manufacture: current methods and future challenges. Trends Biotechnol. 2009;27(7):415-422.
17. von Lindern M, Zauner W, Mellitzer G, et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood. 1999;94(2):550-559. (Pubitemid 29323869)
18. Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol. 2006;24(10):1255-1256. (Pubitemid 44564771)
19. Leberbauer C, Boulme F, Unfried G, Huber J, Beug H, Mullner EW. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood. 2005;105(1):85-94. (Pubitemid 40053068)
20. Douay L. Experimental culture conditions are critical for ex vivo expansion of hematopoietic cells. J Hematother Stem Cell Res. 2001;10:341-346. (Pubitemid 32673239)
21. Hardeman MR, Ince C. Clinical potential of in vitro measured red cell deformability, a myth? Clin Hemorheol Microcirc. 1999;21(3-4):277-284. (Pubitemid 30130904)
22. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods. 1994;171(1):131-137. (Pubitemid 24140219)
23. Anderlini P, Donato M, Chan KW, et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion. 1999;39(6):555-560. (Pubitemid 29275323)
24. Recommended method for radioisotope red-cell survival studies. International Committee for Standardization in Haematology. Br J Haematol. 1980;45(4):659-666.
25. Jansen G, Koenderman L, Rijksen G, Cats BP, Staal GE. Characteristics of hexokinase, pyruvate kinase, and glucose-6-phosphate dehydrogenase during adult and neonatal reticulocyte maturation. Am J Hematol. 1985;20(3):203-215. (Pubitemid 16248064)
26. Bhanu NV, Trice TA, Lee YT, Miller JL. A signaling mechanism for growth-related expression of fetal hemoglobin. Blood. 2004;103(5):1929-1933. (Pubitemid 38268993)
27. Kister J, Poyart C, Edelstein SJ. An expanded two-state allosteric model for interactions of human hemoglobin A with nonsaturating concentrations of 2,3-diphosphoglycerate. J Biol Chem. 1987;262(25):12085-12091. (Pubitemid 17137440)
28. Girard F, Kister J, Bohn B, Poyart C. Functional properties of hemoglobin in human red cells. I. Oxygen equilibrium curves and DPG binding. Respir Physiol. 1987;68(2):227-238. (Pubitemid 17069861)
29. Cline MJ, Berlin NI. The red cell chromium elution rate in patients with some hematologic diseases. Blood. 1963;21:63-69.
30. Mel HC, Prenant M, Mohandas N. Reticulocyte motility and form: studies on maturation and classification. Blood. 1977;49(6):1001-1009. (Pubitemid 8123867)
31. Chasis JA, Prenant M, Leung A, Mohandas N. Membrane assembly and remodeling during reticulocyte maturation. Blood. 1989;74(3):1112-1120. (Pubitemid 19210032)
32. Gronowicz G, Swift H, Steck TL. Maturation of the reticulocyte in vitro. J Cell Sci. 1984;71:177-197.
33. Koury MJ, Koury ST, Kopsombut P, Bondurant MC. In vitro maturation of nascent reticulocytes to erythrocytes. Blood. 2005;105(5):2168-2174. (Pubitemid 40731809)
34. Mairbäurl H, Schulz S, Hoffman JF. Cation transport and cell volume changes in maturing rat reticulocytes. Am J Physiol Cell Physiol. 2000;279(5):C1621-1630.
35. Wiley JS, Shaller CC. Selective loss of calcium permeability on maturation of reticulocytes. J Clin Invest. 1977;59(6):1113-1119. (Pubitemid 8131066)
36. Shattil SJ, Cooper RA. Maturation of macroreticulocyte membranes in vivo. J Lab Clin Med. 1972;79(2):215-227.
37. Waugh RE, McKenney JB, Bauserman RG, Brooks DM, Valeri CR, Snyder LM. Surface area and volume changes during maturation of reticulocytes in the circulation of the baboon. J Lab Clin Med. 1997;129(5):527-535. (Pubitemid 27285049)
38. Liu J, Guo X, Mohandas N, Chasis JA, An X. Membrane remodeling during reticulocyte maturation. Blood. 2010;115(10):2021-2027.
39. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19):9412-9420.
40. Rieu S, Geminard C, Rabesandratana H, Sainte-Marie J, Vidal M. Exosomes released during reticulocyte maturation bind to fibronectin via integrin alpha4beta1. Eur J Biochem. 2000;267(2):583-590. (Pubitemid 30072918)
41. Hughes Jones NC. The life of the red blood cell using chromium 51 (51Cr) as a tracer. Proc R Soc Med. 1962;55:139-141.
42. Ebaugh FG Jr, Emerson CP, Ross JF. The use of radioactive chromium 51 as an erythrocyte tagging agent for the determination or red cell survival in vivo. J Clin Invest. 1953;32(12):1260-1276.
43. Piomelli S, Seaman C, Reibman J, et al. Separation of younger red cells with improved survival in vivo: an approach to chronic transfusion therapy. Proc Natl Acad Sci U S A. 1978;75(7):3474-3478. (Pubitemid 8395095)
44. Awwad HK, Moussa L, Sheraki AS. The effect of red cell aging on chromium-51 binding and in vitro elution. J Nucl Med. 1966;7(9):687-695.
45. Peyrard T, Bardiaux L, Krause C, et al. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev. 2011;25(3):206-216.
46. Cabrita GJ, Ferreira BS, da Silva CL, Goncalves R, Almeida-Porada G, Cabral JM. Hematopoietic stem cells: from the bone to the bioreactor. Trends Biotechnol. 2003;21(5):233-240. (Pubitemid 36519213)
47. Mountford J, Olivier E, Turner M. Prospects for the manufacture of red cells for transfusion. Br J Haematol. 2010;149(1):22-34.
48. Mazurier C, Douay L, Lapillonne H. Red blood cells from induced pluripotent stem cells: hurdles and developments. Curr Opin Hematol. 2011; 18(4):249-253.